Comparison Of Botulinum Toxin Type A Injection Over Conservative Treatment in dystonic movements associated to specific tasks

Comparative Efficacy Of Botulinum Toxin Type A Injection Over Conservative Treatment In Task Specific Dystonia - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072913

Enrollment

Registered

2024-08-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G248- Other dystonia

Interventions

Intervention1: Botulinum Toxin Type A: Botulinum Toxin Type A Injection in specified muscles under Ultrasound guidance dependant on body weight, type of muscle, once and followed up at 1, 4, 12 weeks

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient giving consent 2.FAHN MARSDEN DYSTONIA SCORE more than or equal to 2 3.Symptoms since at least 3 months, 4. Patients with selective writing difficulty, showing improvement with diagnostic intramuscular lignocaine injection

Exclusion criteria

Exclusion criteria: 1.Allergy to botulinum toxin injection 2.Patients presenting with other forms of task specific dystonia as musicians etc 3. Local injection site infection. 4. Patients presenting with hand deformity or contracture. 5.Coagulation disorders, 6. Patients with cognitive deficit 7. Patients injected with botulinum toxin injection in past 3 months. pregnant patients

Design outcomes

Primary

Measure	Time frame
FAHN MARSDEN DYSTONIA SCORE for hand improvementTimepoint: 1, 4 , 12 weeks	—

Secondary

Measure	Time frame
not applicableTimepoint: not applicable	—

Countries

India

Contacts

Public ContactFirdaus Kamal

Institute of Post Graduate Medical Education and Research and SSKM Hospital, Kolkata

kamal.firdaus.kamal@gmail.com9830219554

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026